RXI-109

RXI-109 · RXi Pharmaceuticals, Corp.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for RXI-109, covering 2014-09-17 to 2018-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD [Phase 1, Phase 2]